{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:2062f950-269f-41a3-b297-6b3d99b5af0c","record_version":"public-1:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-16T04:48:15.492176+00:00","published_at":"2026-10-16T04:48:15.492176+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:bv1g1powh4j9","event_type":"CFO_CHANGED","effective_at":"2026-04-03","detected_at":"2026-10-16T04:48:15.492176+00:00","subject_ids":["alpha:person:camille-sebaaly","alpha:company:2062f950-269f-41a3-b297-6b3d99b5af0c"],"caused_claim_ids":["alpha:claim:company:2062f950-269f-41a3-b297-6b3d99b5af0c:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:3f32b72028d3d74df101b4b7e36384862febaf4e0b97ccb18234aa331ad665d8"],"summary":"Camille Sebaaly executive of Sunshine Biopharma Inc., effective 2026-04-03.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1fqhmp1dnn64f","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-04-03","detected_at":"2026-10-16T04:48:15.492176+00:00","subject_ids":["alpha:person:michel-roy","alpha:company:2062f950-269f-41a3-b297-6b3d99b5af0c"],"caused_claim_ids":["alpha:claim:company:2062f950-269f-41a3-b297-6b3d99b5af0c:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:5d888d813da86ccbf64dcf02266b288760b9d01e63914564d05620d710a3613d"],"summary":"Michel Roy executive of Sunshine Biopharma Inc., effective 2026-04-03.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:ainis21vg1sha","event_type":"DIRECTOR_APPOINTED","effective_at":"2022-01-01","detected_at":"2026-10-16T04:48:15.492176+00:00","subject_ids":["alpha:person:david-natan","alpha:company:2062f950-269f-41a3-b297-6b3d99b5af0c"],"caused_claim_ids":["alpha:claim:company:2062f950-269f-41a3-b297-6b3d99b5af0c:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:78b10f484fa7f0e4d758a7585a078bc712c7558263ab13f41cdea71705e169de"],"summary":"David Natan seat on Sunshine Biopharma Inc., effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1cgbgaoalvjvm","event_type":"COMMITTEE_CREATED","effective_at":"2022-01-01","detected_at":"2026-10-16T04:48:15.492176+00:00","subject_ids":["alpha:committee:sunshine-biopharma-inc:audit-chair-compensation-nominating-and-governance","alpha:company:2062f950-269f-41a3-b297-6b3d99b5af0c"],"caused_claim_ids":["alpha:claim:company:2062f950-269f-41a3-b297-6b3d99b5af0c:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:78b10f484fa7f0e4d758a7585a078bc712c7558263ab13f41cdea71705e169de"],"summary":"Audit · Chair; Compensation; Nominating and Governance committee of Sunshine Biopharma Inc., effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:uw68geeb8xpo","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2022-01-01","detected_at":"2026-10-16T04:48:15.492176+00:00","subject_ids":["alpha:person:david-natan","alpha:committee:sunshine-biopharma-inc:audit-chair-compensation-nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:2062f950-269f-41a3-b297-6b3d99b5af0c:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:78b10f484fa7f0e4d758a7585a078bc712c7558263ab13f41cdea71705e169de"],"summary":"David Natan member of Audit · Chair; Compensation; Nominating and Governance, effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:sxj5b0u3gzkc","event_type":"DIRECTOR_APPOINTED","effective_at":"2009-01-01","detected_at":"2026-10-16T04:48:15.492176+00:00","subject_ids":["alpha:person:camille-sebaaly","alpha:company:2062f950-269f-41a3-b297-6b3d99b5af0c"],"caused_claim_ids":["alpha:claim:company:2062f950-269f-41a3-b297-6b3d99b5af0c:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:78b10f484fa7f0e4d758a7585a078bc712c7558263ab13f41cdea71705e169de"],"summary":"Camille Sebaaly seat on Sunshine Biopharma Inc., effective 2009-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:2062f950-269f-41a3-b297-6b3d99b5af0c:leadership_role:5","subject_id":"alpha:company:2062f950-269f-41a3-b297-6b3d99b5af0c","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:camille-sebaaly","object_label":"Camille Sebaaly","object_source_name_forms":[],"value":"Camille Sebaaly: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:camille-sebaaly","name":"Camille Sebaaly"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2009-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2009-01-01","valid_to":null,"recorded_at":"2026-10-16T04:48:15.492176+00:00","sources":[{"id":"alpha:projection-evidence:document:78b10f484fa7f0e4d758a7585a078bc712c7558263ab13f41cdea71705e169de","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Sunshine Biopharma Inc. DEF 14A 2025-10-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1402328/000168316825007747/sunshine_def14a.htm","source_date":"2025-10-23","retrieved_at":"2026-04-28T22:31:01.141+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-10-23","effective_from":"2009-01-01","effective_until":null,"observed_at":"2026-10-16T04:48:15.492176+00:00","reviewed_at":"2026-10-16T04:48:15.492176+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:2062f950-269f-41a3-b297-6b3d99b5af0c:leadership_role:6","subject_id":"alpha:company:2062f950-269f-41a3-b297-6b3d99b5af0c","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:david-natan","object_label":"David Natan","object_source_name_forms":[],"value":"David Natan: Director, Audit · Chair; Compensation; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:david-natan","name":"David Natan"},"title":"Director","role_category":"director","committee":"Audit · Chair; Compensation; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2022-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-10-16T04:48:15.492176+00:00","sources":[{"id":"alpha:projection-evidence:document:78b10f484fa7f0e4d758a7585a078bc712c7558263ab13f41cdea71705e169de","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Sunshine Biopharma Inc. DEF 14A 2025-10-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1402328/000168316825007747/sunshine_def14a.htm","source_date":"2025-10-23","retrieved_at":"2026-04-28T22:31:01.141+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-10-23","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-10-16T04:48:15.492176+00:00","reviewed_at":"2026-10-16T04:48:15.492176+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:2062f950-269f-41a3-b297-6b3d99b5af0c:leadership_role:7","subject_id":"alpha:company:2062f950-269f-41a3-b297-6b3d99b5af0c","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:camille-sebaaly","object_label":"Camille Sebaaly","object_source_name_forms":[],"value":"Camille Sebaaly: Chief Financial Officer, Director and Secretary","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:camille-sebaaly","name":"Camille Sebaaly"},"title":"Chief Financial Officer, Director and Secretary","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-03","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-03","valid_to":null,"recorded_at":"2026-10-16T04:48:15.492176+00:00","sources":[{"id":"alpha:projection-evidence:document:3f32b72028d3d74df101b4b7e36384862febaf4e0b97ccb18234aa331ad665d8","identity_scope":"source_document_reference","source_type":"sec_filing","title":"SBFM 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1402328/000168316826002644/sunshine_i10k-123125.htm","source_date":"2026-04-03T00:00:00+00:00","retrieved_at":"2026-05-16T07:58:02.402095+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-03T00:00:00+00:00","effective_from":"2026-04-03","effective_until":null,"observed_at":"2026-10-16T04:48:15.492176+00:00","reviewed_at":"2026-10-16T04:48:15.492176+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:2062f950-269f-41a3-b297-6b3d99b5af0c:leadership_role:8","subject_id":"alpha:company:2062f950-269f-41a3-b297-6b3d99b5af0c","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:michel-roy","object_label":"Michel Roy","object_source_name_forms":[],"value":"Michel Roy: Chief Commercial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:michel-roy","name":"Michel Roy"},"title":"Chief Commercial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-03","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-03","valid_to":null,"recorded_at":"2026-10-16T04:48:15.492176+00:00","sources":[{"id":"alpha:projection-evidence:document:5d888d813da86ccbf64dcf02266b288760b9d01e63914564d05620d710a3613d","identity_scope":"source_document_reference","source_type":"sec_filing","title":"SBFM 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1402328/000168316826002644/sunshine_i10k-123125.htm","source_date":"2026-04-03T00:00:00+00:00","retrieved_at":"2026-05-16T07:58:02.869177+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-03T00:00:00+00:00","effective_from":"2026-04-03","effective_until":null,"observed_at":"2026-10-16T04:48:15.492176+00:00","reviewed_at":"2026-10-16T04:48:15.492176+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:78b10f484fa7f0e4d758a7585a078bc712c7558263ab13f41cdea71705e169de","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Sunshine Biopharma Inc. DEF 14A 2025-10-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1402328/000168316825007747/sunshine_def14a.htm","source_date":"2025-10-23","retrieved_at":"2026-04-28T22:31:01.141+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:3f32b72028d3d74df101b4b7e36384862febaf4e0b97ccb18234aa331ad665d8","identity_scope":"source_document_reference","source_type":"sec_filing","title":"SBFM 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1402328/000168316826002644/sunshine_i10k-123125.htm","source_date":"2026-04-03T00:00:00+00:00","retrieved_at":"2026-05-16T07:58:02.402095+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:5d888d813da86ccbf64dcf02266b288760b9d01e63914564d05620d710a3613d","identity_scope":"source_document_reference","source_type":"sec_filing","title":"SBFM 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1402328/000168316826002644/sunshine_i10k-123125.htm","source_date":"2026-04-03T00:00:00+00:00","retrieved_at":"2026-05-16T07:58:02.869177+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.817,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.845,"cross_source_agreement":0.75,"temporal_completeness":0.308},"diagnostics":{"published_claims":21,"factual_claims":21,"claims_with_linked_evidence":21,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":13,"temporal_claims_with_valid_from":4,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-16T04:48:15.492176+00:00","observed_at":"2026-10-16T04:48:15.492176+00:00","reviewed_at":"2026-10-16T04:48:15.492176+00:00","verified_at":"2026-10-16T04:48:15.492176+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":21,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/sunshine-biopharma-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/sunshine-biopharma-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}